Anti-CD8 alpha antibody [EPR21769] (Ab217344)

推荐稀释比例

• IHC-P1/2000 Background staining was observed in mouse testis samples. Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
• WB1/1000
• Flow Cyt1/500
• IP1/30
• IHC-Fr1/500

Anti-CD8 alpha antibody [EPR21769] (ab217344) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt, IHC-Fr IHC-P, IP and WB. Anti-CD8 alpha antibody [EPR21769] (ab217344) was first used in a scientific publication in 2019 and has been cited over 164 times in peer reviewed journals. It's performance in IHC and Immunofluorescence in mouse samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-CD8 alpha antibody [EPR21769] (ab217344) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-CD8 alpha antibody [EPR21769] (ab217344) has 4 independent reviews from customers. Anti-CD8 alpha antibody [EPR21769] (ab217344) specifically detects CD8 alpha (UniProt ID: P01731; Molecular weight: 25kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR21769 - ab230156. Antibody clone EPR21769 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, Alexa Fluor ® 647, FITC, APC, Alexa Fluor ® 594, Alexa Fluor ® 555, PE ( ab237364, ab237365, ab237367, ab237368, ab277939, ab280863, ab306536 ). CD8 alpha is involved in diseases by aiding cytotoxic T cells in targeting and eliminating infected or malignant cells. CD8 T cell dysfunction is associated with several diseases including Autoimmune disease, cancer and infectious diseases. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.